Drug Search Results
More Filters [+]

Rimonabant

Alternative Names: rimonabant, sr141716
Latest Update: 2024-05-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CB1 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | European Medicines Agency | Germany | Hungary | India | Ireland | Italy | Peru | Portugal | Slovenia | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rimonabant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Obesity, Abdominal|Insulin Resistance|Other|Overweight|Diabetes, Gestational|Inflammation|Obesity|Dyslipidemia|Cocaine-Related Disorders|Healthy Volunteers|Atherosclerosis|Alcoholism

Phase 3: Coronary Artery Disease|Obesity|Type 2 Diabetes|Dyslipidemia|Spinal Cord Injuries|Obesity, Abdominal|Glucose Intolerance|Tobacco Use Disorder|Smoking Cessation|Atherosclerosis|Myocardial Ischemia|Albuminuria|Non-alcoholic Steatohepatitis|Weight Loss|Prediabetic State|Overweight|Stroke|Fatty Liver, Alcoholic|Non-alcoholic Fatty Liver Disease|Hepatitis, Alcoholic|Myocardial Infarction|Weight Gain|Metabolic Syndrome X|Other|Carotid Stenosis|Arteriosclerosis|Prader-Willi Syndrome|Schizophrenia

Phase 2: Obesity|Affective Disorders, Psychotic|Tobacco Use Disorder|Spinal Cord Injuries|Marijuana Abuse|Psychotic Disorders|Hypertension|Alcoholic Intoxication|Schizophrenia|Polycystic Ovary Syndrome

Phase 1: Marijuana Abuse

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2022-001522-30

P3

Active, not recruiting

Spinal Cord Injuries

2024-09-29

RIMOFATSCI-2

P2

Not yet recruiting

Spinal Cord Injuries

2023-11-01

RIMOFATSCI-1

P2

Completed

Spinal Cord Injuries

2022-06-07

Effec Acomplia gastric sensitivity

P4

Completed

Healthy Volunteers

2021-03-03

Recent News Events